🇺🇸 FDA
Pipeline program

WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL

PROMISE

Approved small_molecule active

Quick answer

WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL for Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a Approved program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
Myocardial infarction with non-obstructive coronary arteries (MINOCA)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials